Literature DB >> 24257601

Novel Woodchuck Hepatitis Virus (WHV) transgene mouse models show sex-dependent WHV replicative activity and development of spontaneous immune responses to WHV proteins.

Zhongji Meng1, Zhiyong Ma, Ejuan Zhang, Anna D Kosinska, Jia Liu, Xiaoyong Zhang, Tianlun Zhou, Jun Wu, Uta Dahmen, Olaf Dirsch, Dongliang Yang, Michael Roggendorf, Mengji Lu.   

Abstract

The woodchuck model is an informative model for studies on hepadnaviral infection. In this study, woodchuck hepatitis virus (WHV) transgenic (Tg) mouse models based on C57BL/6 mice were established to study the pathogenesis associated with hepadnaviral infection. Two lineages of WHV Tg mice, harboring the WHV wild-type genome (lineage 1217) and a mutated WHV genome lacking surface antigen (lineage 1281), were generated. WHV replication intermediates were detected by Southern blotting. DNA vaccines against WHV proteins were applied by intramuscular injection. WHV-specific immune responses were analyzed by flow cytometry and enzyme-linked immunosorbent assays (ELISAs). The presence of WHV transgenes resulted in liver-specific but sex- and age-dependent WHV replication in Tg mice. Pathological changes in the liver, including hepatocellular dysplasia, were observed in aged Tg mice, suggesting that the presence of WHV transgenes may lead to liver diseases. Interestingly, Tg mice of lineage 1281 spontaneously developed T- and B-cell responses to WHV core protein (WHcAg). DNA vaccination induced specific immune responses to WHV proteins in WHV Tg mice, indicating a tolerance break. The magnitude of the induced WHcAg-specific immune responses was dependent on the effectiveness of different DNA vaccines and was associated with a decrease in WHV loads in mice. In conclusion, sex- and age-dependent viral replication, development of autoimmune responses to viral antigens, pathological changes in the liver in WHV Tg mice, and the possibility of breaking immune tolerance to WHV transgenes will allow future studies on pathogenesis related to hepadnaviral infection and therapeutic vaccines.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24257601      PMCID: PMC3911616          DOI: 10.1128/JVI.02086-13

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  37 in total

1.  Transgenic hepatitis B virus mouse model in the study of chemotherapy.

Authors:  John D Morrey
Journal:  Methods Mol Med       Date:  2004

2.  Infection of primary chimpanzee hepatocytes with recombinant hepatitis D virus particles: a surrogate model for hepatitis B virus.

Authors:  Azeneth Barrera; Robert E Lanford
Journal:  Methods Mol Med       Date:  2004

3.  A virus similar to human hepatitis B virus associated with hepatitis and hepatoma in woodchucks.

Authors:  J Summers; J M Smolec; R Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  1978-09       Impact factor: 11.205

4.  In vivo regulation of hepatitis B virus replication by peroxisome proliferators.

Authors:  L G Guidotti; C M Eggers; A K Raney; S Y Chi; J M Peters; F J Gonzalez; A McLachlan
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

Review 5.  Hepatocellular carcinoma in the woodchuck model of hepatitis B virus infection.

Authors:  Bud C Tennant; Ilia A Toshkov; Simon F Peek; James R Jacob; Stephan Menne; William E Hornbuckle; Raymond D Schinazi; Brent E Korba; Paul J Cote; John L Gerin
Journal:  Gastroenterology       Date:  2004-11       Impact factor: 22.682

6.  Replication and gene expression of hepatitis B virus in a transgenic mouse that contains the complete viral genome.

Authors:  H Farza; M Hadchouel; J Scotto; P Tiollais; C Babinet; C Pourcel
Journal:  J Virol       Date:  1988-11       Impact factor: 5.103

Review 7.  Advances in therapy for chronic hepatitis B.

Authors:  Patrick Marcellin
Journal:  Semin Liver Dis       Date:  2002       Impact factor: 6.115

8.  Viral hepatitis, type B, in experimental animals.

Authors:  L F Barker; J E Maynard; R H Purcell; J H Hoofnagle; K R Berquist; W T London
Journal:  Am J Med Sci       Date:  1975 Jul-Aug       Impact factor: 2.378

9.  Combination of DNA prime--adenovirus boost immunization with entecavir elicits sustained control of chronic hepatitis B in the woodchuck model.

Authors:  Anna D Kosinska; Ejuan Zhang; Lena Johrden; Jia Liu; Pia L Seiz; Xiaoyong Zhang; Zhiyong Ma; Thekla Kemper; Melanie Fiedler; Dieter Glebe; Oliver Wildner; Ulf Dittmer; Mengji Lu; Michael Roggendorf
Journal:  PLoS Pathog       Date:  2013-06-13       Impact factor: 6.823

10.  Transcription of woodchuck hepatitis virus in the chronically infected liver.

Authors:  T Möröy; J Etiemble; C Trépo; P Tiollais; M A Buendia
Journal:  EMBO J       Date:  1985-06       Impact factor: 11.598

View more
  4 in total

1.  Activity of nucleic acid polymers in rodent models of HBV infection.

Authors:  Katrin Schöneweis; Neil Motter; Pia L Roppert; Mengji Lu; Baoju Wang; Ingo Roehl; Dieter Glebe; Dongliang Yang; John D Morrey; Michael Roggendorf; Andrew Vaillant
Journal:  Antiviral Res       Date:  2017-11-08       Impact factor: 5.970

2.  Persistence of the recombinant genomes of woodchuck hepatitis virus in the mouse model.

Authors:  Danzhen Pan; Yong Lin; Weimin Wu; Jingjiao Song; Ejuan Zhang; Chunchen Wu; Xinwen Chen; Kanghong Hu; Dongliang Yang; Yang Xu; Mengji Lu
Journal:  PLoS One       Date:  2015-05-05       Impact factor: 3.240

3.  Imaging, Pathology, and Immune Correlates in the Woodchuck Hepatic Tumor Model.

Authors:  Michal Mauda-Havakuk; Andrew S Mikhail; Matthew F Starost; Elizabeth C Jones; Baktiar Karim; David E Kleiner; Ari Partanen; Juan A Esparza-Trujillo; Ivane Bakhutashvili; Paul G Wakim; Michael T Kassin; Andrew L Lewis; John W Karanian; Bradford J Wood; William F Pritchard
Journal:  J Hepatocell Carcinoma       Date:  2021-03-09

4.  Virological activity in treatment-naïve HBeAg-negative HBV-infected adult patients: A community-based study in Jiangsu, China.

Authors:  Xiangjun Zhai; Liguo Zhu; Jie Jiang; Ci Song; Hong Peng; Jiao Qian; MingHao Zhou; Yan Zhou; Qungang Wang; Jianfang Xu; Zhijian Wang; Hongjian Liu; Min Fan; Zhibin Hu; Hongbin Shen; Fengcai Zhu
Journal:  Medicine (Baltimore)       Date:  2020-07-17       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.